Jeff Yass’s Sanara MedTech SMTI Stock Holding History

Jeff Yass’s Portfolio SMTI Stock Details SMTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,250	Closed	-$263K	–	13769
2025 Q2	$263K	Buy	+9,250	New	+$277K	﹤0.01%	10638
2023 Q2	–	Sell	-25,295	Closed	-$1.04M	–	13056
2023 Q1	$1.04M	Buy	25,295 +10,068	+66%	+$425K	﹤0.01%	6710
2022 Q4	$693K	Buy	+15,227	New	+$525K	﹤0.01%	7043
2022 Q2	–	Sell	-15,000	Closed	-$416K	–	13862
2022 Q1	$416K	Sell	15,000 -1,800	-11%	-$45.7K	﹤0.01%	9446
2021 Q4	$511K	Buy	16,800 +3,900	+30%	+$123K	﹤0.01%	9147
2021 Q3	$439K	Buy	+12,900	New	+$463K	﹤0.01%	9719
2021 Q2	–	Sell	-10,373	Closed	-$323K	–	13211
2021 Q1	$323K	Buy	+10,373	New	+$359K	﹤0.01%	10449

Other funds holding SMTI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SWM

Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

Jeff Yass's SMTI Position: Q3 2025 in Review

Jeff Yass sold out of Sanara MedTech (SMTI) in Q3 2025, closing a stake of 9,250 shares — an estimated $263K sold.

Jeff Yass first reported a position in SMTI in Q1 2021 and held it in 7 quarters. The position peaked at $1.04M in Q1 2023. 58 funds tracked by Wall St. Rank hold SMTI as of Q3 2025.

Jeff Yass reported no remaining Sanara MedTech position as of Q3 2025 after selling out during the quarter.
Jeff Yass sold 9,250 Sanara MedTech shares in Q3 2025, an estimated $263K.
Jeff Yass first reported a position in Sanara MedTech in Q1 2021 and held it in 7 quarters.
Jeff Yass's Sanara MedTech position peaked at $1.04M in Q1 2023.
58 funds tracked by Wall St. Rank held Sanara MedTech as of Q3 2025.

Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.